Kidney Biopsy Market Report: Analysis, Share, Trend, Segmentation, Top Leaders, Forecast To 2033

Global kidney biopsy market size is expected to reach $2.66 Bn by 2028 at a rate of 5.5%, segmented as by type, percutaneous biopsy, surgical biopsy

Share this Post to earn Money ( Upto ₹100 per 1000 Views )


Kidney Biopsy Market Report: Analysis, Share, Trend, Segmentation, Top Leaders, Forecast To 2033

The kidney biopsy from The Business Research Company provides comprehensive market statistics, including global market size, regional shares, competitor market share, detailed segments, trends, and opportunities. This report offers an in-depth analysis of current and future industry scenarios, delivering a complete perspective for thriving in the industrial automation software market.

Kidney Biopsy Market, 2024 report by The Business Research Company offers comprehensive insights into the current state of the market and highlights future growth opportunities.

Market Size -
The kidney biopsy market size has grown strongly in recent years. It will grow from $2.03 billion in 2023 to $2.14 billion in 2024 at a compound annual growth rate (CAGR) of 5.3%. The growth in the historic period can be attributed to increased chronic kidney diseases, rise in awareness about early diagnosis, surge in geriatric population, expansion of healthcare infrastructure, enhanced government initiatives for kidney disease management, and rise in awareness of kidney health.

The kidney biopsy market size is expected to see strong growth in the next few years. It will grow to $2.66 billion in 2028 at a compound annual growth rate (CAGR) of 5.5%. The growth in the forecast period can be attributed to increasing prevalence of kidney diseases, rising healthcare expenditure, growing awareness about early diagnosis, expanding geriatric population, rising demand for minimally invasive procedures, and increasing research activities. Major trends in the forecast period include technological advancements in biopsy techniques, adoption of minimally invasive procedures, advancements in imaging technologies, integration of artificial intelligence for better precision, and technological innovations in biopsy devices.

Order your report now for swift delivery @
https://www.thebusinessresearchcompany.com/report/kidney-biopsy-global-market-report

Scope Of Kidney Biopsy Market
The Business Research Company's reports encompass a wide range of information, including:
1. Market Size (Historic and Forecast): Analysis of the market's historical performance and projections for future growth.
2. Drivers: Examination of the key factors propelling market growth.
3. Trends: Identification of emerging trends and patterns shaping the market landscape.
4. Key Segments: Breakdown of the market into its primary segments and their respective performance.
5. Focus Regions and Geographies: Insight into the most critical regions and geographical areas influencing the market.
6. Macro-Economic Factors: Assessment of broader economic elements impacting the market.

Kidney Biopsy Market Overview
Market Drivers -
The rise in the incidence of renal cancer is expected to propel the growth of the kidney biopsy market going forward. Renal cancer is characterized by the uncontrolled growth of abnormal kidney cells. The rise in renal cancer is attributed to factors such as changes in lifestyle, environmental toxins, and better detection techniques that result in more diagnoses. A kidney biopsy helps diagnose and manage renal cancer by confirming the presence of cancerous cells, determining cancer grade, planning treatment, monitoring treatment response, and providing prognostic information. For instance, according to Cancer Research UK, a UK-based cancer research organization, the new kidney cancer cases are expected to increase from approximately 16,300 in 2023 to about 21,900 in 2025. Therefore, the rise in the incidence of renal cancer is driving the growth of the kidney biopsy market.

Market Trends -
Major companies operating in the kidney biopsy market are developing innovative platforms by integrating with artificial intelligence (AI) to enhance diagnostic accuracy, streamline procedures, and improve patient outcomes. Artificial intelligence (AI) enhances kidney biopsy by improving image analysis, providing diagnostic support, aiding in treatment planning, offering predictive analytics, and advancing research in kidney diseases. For instance, in March 2024, Aiosyn, a Netherlands-based software company, launched the NephroPath platform. The NephroPath platform uses computational pathology algorithms to analyze histological biomarkers in kidney biopsies, including identifying tissue types, measuring interstitial fibrosis, and precisely counting and assessing glomeruli. This AI-driven analysis ensures consistent, detailed, and reproducible scoring of renal pathology biomarkers, overcoming the drawbacks of traditional scoring methods and observer subjectivity.

The kidney biopsy market covered in this report is segmented –
1) By Type: Percutaneous Biopsy, Surgical Biopsy
2) By Indication: Kidney Failure, Kidney Transplant, Hematuria, Proteinuria
3) By End-User: Hospitals And Clinics, Urology Centers, Tertiary Care Centers, Other End-Users

Get an inside scoop of the kidney biopsy market, Request now for Sample Report @
https://www.thebusinessresearchcompany.com/sample.aspx?id=16458&type=smp

Regional Insights -
North America was the largest region in the kidney biopsy market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the kidney biopsy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Key Companies -
Major companies operating in the kidney biopsy market are Cardinal Health, Pfizer Inc., Merck & Co. Inc., Thermo Fisher Scientific Inc., AstraZeneca , Medtronic, Siemens Healthcare Private Limited, Becton, Dickinson and Company, Strykar Healthcare, Baxter International Inc., Boston Scientific Corporation, F. Hoffmann-La Roche Ltd., Zimmer Biomet, Agilent Technologies Inc., Olympus Corporation, Hitachi High-Tech Corporation, Beckman Coulter Inc. , B. Braun, Sysmex Corporation, Cook Medical, Bio-Rad Laboratories Inc., Integra LifeSciences Corporation, Merit Medical Systems, Leica Biosystems Nussloch GmbH, Argon Medical Devices Inc., BioGenex

Table of Contents
1. Executive Summary
2. Kidney Biopsy Market Report Structure
3. Kidney Biopsy Market Trends And Strategies
4. Kidney Biopsy Market – Macro Economic Scenario
5. Kidney Biopsy Market Size And Growth
…..
27. Kidney Biopsy Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model